New cancer clinical trial: A Study of Dacomitinib in Patients With Metastatic EGFR Mutant Lung Cancer Previously Treated With Osimertinib

Published on: November 27, 2018 at 12:00PM
Conditions:   EGFR Gene Mutation;   Lung Cancer;   Lung Cancer Metastatic
Intervention:   Drug: Dacomitinib
Sponsor:   Memorial Sloan Kettering Cancer Center
Recruiting
https://ift.tt/2AtL0CV